(REGN:Consolidated Issue Listed on NASDAQ Global Select )
Marc Tessier-Lavigne Ph.D.
Director, Chairman of Compensation Committee and Member of Technology Committee, Regeneron Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 84 board members in 7 different organizations across 6 different industries.|
See Board Relationships
Dr. Marc Tessier-Lavigne, Ph.D. has been the President of The Rockefeller University since 2011, where Dr. Tessier-Lavigne also serves as a professor and head of the laboratory of brain development and repair. He is a Co-founder of Renovis Inc. He joined The Rockefeller University in 2011. He served as the Chief Scientific Officer and Executive Vice President of Research of Genentech, Inc. He served as an Executive Vice President of Research Drug Discovery of Genentech ...
777 Old Saw Mill River RoadPhone: 914-847-7000
Tarrytown, New York 10591
Board Members Memberships*
Director, Chairman of Compensation Committee and Member of Technology Committee
Independent Director, Member of Regulatory & Compliance Committee, Member of Regulatory & Compliance Committee and Member of Science & Technology Committee
Director, Chairman of Compensation Committee and Chairman of Science & Technology Committee
University of Oxford
University College London
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|Jean-Jacques Bienaime MBA||Chief Executive Officer and Director|
BioMarin Pharmaceutical Inc.
|Jeffrey M. Leiden M.D., Ph.D.||Chairman, Chief Executive Officer and President|
Vertex Pharmaceuticals Incorporated
|Leonard Bell M.D.||Co-Founder, Chairman of the Board and Chief Executive Officer|
Alexion Pharmaceuticals, Inc.
|Nobuo Hanai Ph.D.||Chief Executive Officer, President and Representative Director|
Kyowa Hakko Kirin Co., Ltd.
|Jean-Christophe Tellier||Chief Executive Officer and Director|
|--||Compensation as of Fiscal Year 2013.|